Form 4 for CELC Celcuity Inc.
Accepted 2022-05-19 00:00:00 ET · period of report 2022-05-17 · accession 0001437749-22-013129 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-05-19 | 2022-05-17 | CELC | Buller Richard E | Dir | A - Grant | $0.00 | +3,273 | 11.8K | +38% | $0 |
| DM | 2022-05-19 | 2022-05-17 | CELC | Buller Richard E | Dir | D - Sale to Iss | — | -6,865 | 0 | -100% | — |
| DM | 2022-05-19 | 2022-05-17 | CELC | Buller Richard E | Dir | A - Grant | $0.00 | +26.4K | 19.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-17 | A | A | 3,273 | $0.00 | 11,798 | D | — | — | (F1) Represents 3,273 shares of restricted stock for which risks of forfeiture lapse on April 30, 2023, or if earlier, the date of the Company's 2023 Annual Meeting of Stockholders. |
| 2 | Derivative | Stock Option (right to buy) | 2022-05-17 | D | D | 4,555 | — | 0 | D | $10.68 · — to 2029-12-03 | 4,555 Common Stock | (F4) The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. (F2) 100% vested. |
| 3 | Derivative | Stock Option (right to buy) | 2022-05-17 | A | A | 4,555 | — | 4,555 | D | $5.50 · — to 2029-12-03 | 4,555 Common Stock | (F4) The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. (F2) 100% vested. |
| 4 | Derivative | Stock Option (right to buy) | 2022-05-17 | A | A | 2,310 | — | 2,310 | D | $5.50 · — to 2031-05-12 | 2,310 Common Stock | (F4) The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. (F2) 100% vested. |
| 5 | Derivative | Stock Option (right to buy) | 2022-05-17 | D | D | 2,310 | — | 0 | D | $26.99 · — to 2031-05-12 | 2,310 Common Stock | (F4) The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. (F2) 100% vested. |
| 6 | Derivative | Stock Option (right to buy) | 2022-05-17 | A | A | 19,558 | $0.00 | 19,558 | D | $5.50 · — to 2032-05-17 | 19,558 Common Stock | (F3) This Option will vest and become exercisable on April 30, 2023, or if earlier, the date of the Company's 2023 Annual Meeting of Stockholders. |